Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network
Chloroquine (CQ) and L-Arginine (100 mg/kg) treated tissues exhibited severe damage with disruption, vacuolization, thickness of epidermis (first skin layer) and deformed cells
Protocol approach 1: immune rebalancing (thymosin alpha-1 plus KPV) Goal: Restore regulatory immune function while reducing inflammatory signaling Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week (promotes Treg expansion, modulates dendritic cells) KPV: 200-500 mcg daily, orally or subcutaneously (inhibits NF-kB, reduces TNF-alpha and IL-6) Rationale: Thymosin alpha-1 works at the cellular level to rebuild the regulatory arm of the immune system, while KPV addresses the inflammatory signaling that drives acute symptoms
Is J1815 an NDC number
Curr Top Med Chem 13(21):26482659 Barneche S, Albors S, Borthagaray G, Cerdeiras MP, Vzquez A (2017) Anti-MRSA activ ity of fruiting body extracts of spectacular Rustgill mushroom, Gymnopilus junonius (Agaricomycetes)